NCT01940328

Brief Summary

The purpose of this study is to evaluate the lung Doppler signals in left HF patients with and without pulmonary congestion (i.e. decompensated left HF patients and compensated left HF patients respectively), in comparison to a control group of subjects without CHF (non-CHF controls), in order to determine the diagnostic value of this non-invasive method in CHF. If this method will prove to be of diagnostic value, it could potentially be used to diagnose and monitor CHF patients in both inpatient and outpatient settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 12, 2013

Completed
19 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

February 8, 2017

Status Verified

August 1, 2013

Enrollment Period

2.2 years

First QC Date

September 9, 2013

Last Update Submit

February 7, 2017

Conditions

Keywords

Ultrasound DopplerCongestive heart failurePulmonary Edema

Outcome Measures

Primary Outcomes (1)

  • Diagnose specific pattern of LDS in patients by features as velocity, power etc in comparison to controls

    1.5y to collect all data and obtain a diagnostic pattern

Study Arms (3)

Decompensated CHF

patients with acute pulmonary congestion or pulmonary edema

Device: Transchoracic ultrasound Doppler

Compensated CHF

patients with significant stable left HF (NYHA II-III) who are on optimal medical treatment for CHF, and are without clinical or laboratory evidence of pulmonary congestion

Device: Transchoracic ultrasound Doppler

Non CHF patients

patients without CHF and without uncontrolled hypertension.

Device: Transchoracic ultrasound Doppler

Interventions

Compensated CHFDecompensated CHFNon CHF patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 150 mpatients will be recruited during 18 months: 50 Acute decompensated left heart failure;50 compensated left heart failure;50 non-CHF controls.

You may qualify if:

  • Age over 18 years
  • Belongs to one of the following categories:
  • A. Acute decompensated left HF: patients with acute pulmonary congestion or pulmonary edema diagnosed on the basis of all of the following criteria:
  • Dyspnea at rest or with minimal activity
  • Rales on auscultation
  • Evidence of pulmonary congestion or edema on chest X-ray.
  • BNP level \>400 pg/ml
  • B. Compensated left HF: patients with significant stable left HF (NYHA II-III) who are on optimal medical treatment for CHF, and are without clinical or laboratory evidence of pulmonary congestion. The following 3 criteria must be met:
  • No dyspnea at rest
  • No rales on auscultation
  • BNP levels \< 100 pg/ml
  • C. Non-CHF controls: patients without CHF and without uncontrolled hypertension.
  • Signed Informed Consent

You may not qualify if:

  • \- Decompensated left HF subgroup \& Non CHF controls
  • Non-cardiogenic pulmonary edema or lung injury (e.g. ARDS)
  • Interstitial lung disease
  • Severe kyphosis, scoliosis or chest wall deformity
  • Pregnant women
  • Compensated left HF subgroup
  • Chronic obstructive pulmonary disease (COPD)
  • Asthma
  • Interstitial lung disease
  • Any other obstructive or restrictive lung diseases
  • Non-cardiogenic pulmonary edema or lung injury (e.g. ARDS)
  • Current or past pulmonary embolism
  • Large right sided pleural effusion
  • Severe kyphosis, scoliosis or chest wall deformity
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EMD Rambam Hospital

Haifa, Israel

Location

MeSH Terms

Conditions

Pulmonary EdemaHeart Failure

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHeart DiseasesCardiovascular Diseases

Study Officials

  • Shmuel Rispler, MD, PhD

    Rambam Health Care Campus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2013

First Posted

September 12, 2013

Study Start

October 1, 2013

Primary Completion

December 1, 2015

Study Completion

March 1, 2016

Last Updated

February 8, 2017

Record last verified: 2013-08

Locations